Lundbeck
HLUN-B.CO
#2735
Rank
A$8.96 B
Marketcap
A$9.04
Share price
0.38%
Change (1 day)
-12.48%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): A$1.13

According to Lundbeck's latest financial reports the company's current EPS (TTM) is A$1.06. In 2025 the company made an earnings per share (EPS) of A$0.71 an increase over its 2024 EPS that were of A$0.62.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.1358.63%
2025A$0.7114.5%
2024A$0.6229.29%
2023A$0.4823.09%
2022A$0.3937.26%
2021A$0.29-84.61%
2020A$1.86-24.61%
2019A$2.46-42.06%
2018A$4.2540.7%
2017A$3.02146.26%
2016A$1.23-120.48%
2015A-$5.993231.32%
2014A-$0.18-115.78%
2013A$1.14-23.36%
2012A$1.49-48.01%
2011A$2.86-9.68%
2010A$3.1613.72%
2009A$2.7824.32%
2008A$2.24-6.05%
2007A$2.3881.77%
2006A$1.31-16.76%
2005A$1.57-17.58%
2004A$1.91